摘要
哮喘是一种慢性气道炎症性疾病。哮喘控制药物通过抗炎作用控制哮喘的慢性气道炎症、从而预防哮喘发作,是哮喘药物治疗的重要组成。本文就常用的几类哮喘控制药物(包括糖皮质激素、长效β2-受体激动剂、白三烯受体拮抗剂和茶碱缓释制剂)的安全性作一概述,以期医生和药师能更合理、安全地使用这些药物。
Asthma is a chronic inlfammatory disease of airway. Asthma-controlling medicine is an important component for the treatment of asthma and the chronic airway inlfammation can be controlled through its anti-inlfammatory action so as to prevent asthma attack. This article brielfy introduces the safety of some kinds of common asthma-controlling medicines, including glucocorticoids, long-acting β2-receptor agonists, leukotriene receptor antagonists and sustained-release theophyline so that doctors and pharmacists can more reasonably and safely use them.
出处
《上海医药》
CAS
2014年第5期20-23,共4页
Shanghai Medical & Pharmaceutical Journal
关键词
哮喘
药物
安全性
asthma
medicines
safety